Editas Medicine (EDIT) Total Liabilities: 2015-2025
Historic Total Liabilities for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $188.3 million.
- Editas Medicine's Total Liabilities rose 23.93% to $188.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.3 million, marking a year-over-year increase of 23.93%. This contributed to the annual value of $207.3 million for FY2024, which is 38.16% up from last year.
- According to the latest figures from Q3 2025, Editas Medicine's Total Liabilities is $188.3 million, which was down 1.62% from $191.4 million recorded in Q2 2025.
- Editas Medicine's 5-year Total Liabilities high stood at $207.3 million for Q4 2024, and its period low was $110.3 million during Q1 2022.
- Its 3-year average for Total Liabilities is $165.6 million, with a median of $151.9 million in 2024.
- In the last 5 years, Editas Medicine's Total Liabilities crashed by 38.71% in 2021 and then surged by 38.16% in 2024.
- Quarterly analysis of 5 years shows Editas Medicine's Total Liabilities stood at $123.8 million in 2021, then climbed by 24.06% to $153.6 million in 2022, then dropped by 2.33% to $150.1 million in 2023, then surged by 38.16% to $207.3 million in 2024, then rose by 23.93% to $188.3 million in 2025.
- Its last three reported values are $188.3 million in Q3 2025, $191.4 million for Q2 2025, and $201.2 million during Q1 2025.